Can Fite Biopharma News

Can Fite Biopharma Aktie VALOR 47731043 / ISIN US13471N2018

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Trading-Depot

Aktion

Portfolio

Watchlist

18.03.25	Can-Fite BioPharma To Offer Compassionate Use Program With Namodenoson - Quick Facts (RTTNews)
18.12.23	Can-Fite Reports FDA Positive Response To Its Psoriasis Pediatric Plan - Quick Facts (RTTNews)
18.08.23	Can-Fite Submits Pediatric Study Plan To Allow Registration Of Piclidenoson (RTTNews)
13.06.23	Can-Fite To Seek FDA Clearance For Phase II Trial Of Namodenoson In Pancreatic Cancer (RTTNews)
05.06.23	Pre-market Movers: FRZA, CJET, CIR, EVAX, DAWN… (RTTNews)
11.05.23	Pre-market Movers: GFAI, SONO, KLXE, CDNA, DMRC… (RTTNews)
10.04.23	Can-Fite: CHMP Issues Positive Opinion On Piclidenoson Phase III Clinical Trial (RTTNews)
08.03.23	Pre-market Movers: FRTX, RIGL, INBS, MAXN, CVM… (RTTNews)
30.01.23	Pre-market Movers: GMVD, BBAI, OBIO, IXHL, APE… (RTTNews)
23.01.23	Pre-market Movers: PLRX, SFR, PIXY, ICD, COSM… (RTTNews)
10.01.23	Can-Fite Submits Market Registration Plan To EMA For Piclidenoson In Psoriasis Treatment (RTTNews)
31.10.22	EQS-News: This Company Is Racing Toward Providing Comfort And Safety To Millions Of Psoriasis Sufferers (EQS Group)
23.08.22	Can-Fite: Namodenoson Gets Approval In Romania For Compassionate Use To Treat Advanced Liver Cancer (RTTNews)
29.06.22	Can-Fite's Piclidenoson To Treat Plaque Psoriasis Meets Main Goal In Late-stage COMFORT Study (RTTNews)
21.12.21	Pre-market Movers: ARDS, RELI, ALDX, QNRX, AQST… (RTTNews)
20.12.21	Can-Fite: Complete Response Of HCC Observed In Patient Treated With Namodenoson (RTTNews)
23.11.21	Pre-market Movers: PTPI, ISPC, QLGN, AADI, BTB… (RTTNews)
28.06.21	Can-Fite BioPharma Signs Deal With Vetbiolix For Development Of Piclidenoson For Pets (RTTNews)
25.03.21	Can-Fite BioPharma FY Net Loss Widens - Quick Facts (RTTNews)
17.03.21	CELC Inks Breast Cancer Trial Collaboration, CANF Soars On Deal With Ewopharma, MRUS On Watch (RTTNews)
15.07.20	Stock Alert: Can-Fite Shares Up 33% In Early Trade (RTTNews)
15.07.20	Can-Fite Amends Phase II COVID-19 Study Protocol Based On Inputs From FDA (RTTNews)
13.04.20	Can-Fite Gets Approval For COVID-19 Clinical Trial For Piclidenoson In Israel (RTTNews)
09.03.20	Can-Fite (CANF) To Report NASH Study Data In March (RTTNews)
05.03.20	Can Fite To Explore Anti-viral Effect Of Piclidenoson Against Coronavirus (RTTNews)
29.11.19	Catalysts Aplenty For Can-Fite (CANF) (RTTNews)

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’048.00	8.65 %	K V
Swiss Re	140.00	7.12 %	K V
Logitech Intl	59.92	7.11 %	K V
UBS Group	23.40	6.70 %	K V
CieFinRichemont	137.40	6.47 %	K V
Roche Hldg G	244.40	3.82 %	K V
Novartis	85.64	3.23 %	K V
Geberit	529.20	2.64 %	K V
Nestle	84.45	1.44 %	K V
Swisscom	506.50	0.00 %	K V